Literature DB >> 12076713

Superoxide dismutase and total anti-oxidant levels in various forms of liver diseases.

M Irshad1, P S. Chaudhuri, Y K. Joshi.   

Abstract

In order to understand the impact of viral hepatitis on anti-oxidant defence system of the body, blood levels of superoxide dismutase (SOD), an enzymatic anti-oxidant, and total anti-oxidant (TAO) were evaluated and co-related to etiological viral hepatitis in various forms of liver diseases. A total number of 110 patients including 50 patients with acute viral hepatitis (AVH), 30 patients with chronic active hepatitis (CAH) and 30 patients with cirrhosis of liver were analysed for different hepatitis viral markers and the anti-oxidant levels in their blood. For comparison, blood from 100 healthy persons were also simultaneously tested for anti-oxidant levels. Analysis of results indicated that none of the patients belonging to these three liver diseases had hepatitis A viral (HAV) and hepatitis D viral (HDV) infections. AVH group had mainly hepatitis B viral (HBV), hepatitis C viral (HCV) and hepatitis E viral (HEV) infections, CAH group had B and C infections and cirrhosis group had B, C and E infections. A sizeable number of patients in each group had no markers and were labelled as non-BCE group. On co-relating anti-oxidant levels to viral etiology in these patients, it was observed that in comparison to healthy control group, SOD level was significantly reduced in all the patients irrespective of the viral etiology (P<0.05-0.001). The impact of different viruses on reduction in SOD level was recorded to be the same with no significant difference in SOD level between any two viral infections. On the contrary, TAO level in the majority of patients was found to be comparable with that observed in healthy persons. An appreciable change in SOD level but little impact on TAO level during viral hepatitis may be explained by the possible adaptive rise of some other anti-oxidant level in the blood of these patients.

Entities:  

Year:  2002        PMID: 12076713     DOI: 10.1016/s1386-6346(01)00181-4

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  14 in total

1.  Serum NOX2 as a new biomarker candidate for HBV-related disorders.

Authors:  Yuan Xiong; Yuanyuan Ye; Pu Li; Yahui Xiong; Jinju Mao; Yong Huang; Weixian Chen; Bo Wang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Cellular immune response to infection by different genotypes of hepatitis C virus.

Authors:  Mohamed El-Shahat Ebeid; Kadry Abdel-Kader El-Bakry
Journal:  Indian J Clin Biochem       Date:  2009-09-16

3.  Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.

Authors:  H Karsen; I Binici; M Sunnetcioglu; A I Baran; M R Ceylan; S Selek; H Celik
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

4.  Torque teno virus: its prevalence and isotypes in North India.

Authors:  Mohammad Irshad; Shiwani Singh; Khushboo Irshad; Sanjay-Kumar Agarwal; Yogendra-Kumar Joshi
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

5.  Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection.

Authors:  Cengiz Bolukbas; Fusun Filiz Bolukbas; Mehmet Horoz; Mehmet Aslan; Hakim Celik; Ozcan Erel
Journal:  BMC Infect Dis       Date:  2005-10-31       Impact factor: 3.090

6.  Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy.

Authors:  Görenek Levent; Acar Ali; Aydin Ahmet; Eyigun Can Polat; Cetinkaya Aytaç; Eken Ayşe; Sayal Ahmet
Journal:  J Transl Med       Date:  2006-06-20       Impact factor: 5.531

Review 7.  Hepatitis B and its Relationship With Oxidative Stress.

Authors:  Seyed Moayed Alavian; Alireza Showraki
Journal:  Hepat Mon       Date:  2016-07-17       Impact factor: 0.660

8.  Persistent oxidative stress in patients with chronic active hepatitis-C infection after antiviral therapy failure.

Authors:  Ghada El-Kannishy; Mona Arafa; Ibrahim Abdelaal; Mohamed Elarman; Rasha El-Mahdy
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

9.  Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis.

Authors:  Seren Ozenirler; Banu Sancak; Ugur Coskun
Journal:  Biomark Insights       Date:  2008-03-12

10.  Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein Expression.

Authors:  Ji-Hua Ren; Xiang Chen; Li Zhou; Na-Na Tao; Hong-Zhong Zhou; Bo Liu; Wan-Yu Li; Ai-Long Huang; Juan Chen
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.